Description:

SITAGLIPTIN - FDA APPROVED DDP-IV INHIBITOR ,INCREASES CONCENTRATION OF GLP -1 ET GIP THERAPY . METFORMIN - REDUCES A STEADY BLOOD LEVEL OF A DRUG THROUGHOUT THE DAY AGAINST TYPE II DIABETES * SUPPORT DIRECT CARDIOVASCULAR EFFECTS .